225 related articles for article (PubMed ID: 33965858)
1. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma.
Lema BE; Patricio GM; Kreimann EL
Acta Histochem; 2021 Jul; 123(5):151717. PubMed ID: 33965858
[TBL] [Abstract][Full Text] [Related]
2. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
3. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
4. Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas.
Demacopulo B; Lema BE; Cabrini RL; Kreimann EL
Acta Histochem; 2016 Oct; 118(8):797-805. PubMed ID: 27823775
[TBL] [Abstract][Full Text] [Related]
5. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract][Full Text] [Related]
6. NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma.
Aksionau A; Silva RA; Hartman B; Flowers A
Transl Androl Urol; 2023 Aug; 12(8):1283-1295. PubMed ID: 37680228
[TBL] [Abstract][Full Text] [Related]
7. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
8. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
[TBL] [Abstract][Full Text] [Related]
9. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nuclear NHERF1 in colorectal cancer progression.
Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G
Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563
[TBL] [Abstract][Full Text] [Related]
11. Expression of NHERF1 in colonic tumors induced by 1,2-dimethylhydrazine in rats is independent of plasma ovarian steroids.
Troncoso M; Cuello Carrión FD; Guiñazu E; Fanelli MA; Montt-Guevara M; Cabrini RL; Carón RW; Kreimann EL
Horm Cancer; 2011 Aug; 2(4):214-23. PubMed ID: 21761111
[TBL] [Abstract][Full Text] [Related]
12. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
13. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
14. Alteration in the sensitivity to crizotinib by Na
Yang F; Hu M; Chang S; Huang J; Si Y; Wang J; Cheng S; Jiang WG
BMC Cancer; 2020 Mar; 20(1):202. PubMed ID: 32164629
[TBL] [Abstract][Full Text] [Related]
15. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.
Morales FC; Takahashi Y; Kreimann EL; Georgescu MM
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17705-10. PubMed ID: 15591354
[TBL] [Abstract][Full Text] [Related]
16. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
Shankar A; Crouch DH; Macluskey M
Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
[TBL] [Abstract][Full Text] [Related]
17. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma.
Wang L; Du YR; Ji MY; Wang W; Zhan N; Zhou QS; Dong WG
Eur Rev Med Pharmacol Sci; 2014; 18(24):3854-63. PubMed ID: 25555876
[TBL] [Abstract][Full Text] [Related]
18. Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function.
Kreimann EL; Morales FC; de Orbeta-Cruz J; Takahashi Y; Adams H; Liu TJ; McCrea PD; Georgescu MM
Oncogene; 2007 Aug; 26(36):5290-9. PubMed ID: 17325659
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma.
Matsumoto T; Yoki A; Konno R; Oguri Y; Hashimura M; Tochimoto M; Nakagawa M; Jiang Z; Ishibashi Y; Ito T; Kodera Y; Saegusa M
Carcinogenesis; 2021 Oct; 42(9):1162-1170. PubMed ID: 34323956
[TBL] [Abstract][Full Text] [Related]
20. Distribution dynamics and functional importance of NHERF1 in regulation of Mrp-2 trafficking in hepatocytes.
Karvar S; Suda J; Zhu L; Rockey DC
Am J Physiol Cell Physiol; 2014 Oct; 307(8):C727-37. PubMed ID: 25163515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]